INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
WC
Wall Cecil CDirector
TMRCDyTb, LLC
Grant or award
A$18K
23.1K sh
Jan 5, 2026Jan 8, 2026
Page 1516 of 1814
← PrevNext →
traded Jan 5, 2026
+3d
SEC Form 4

Evidence

15
MA
Marathe AjayChief Operating Officer
ENVXEnovix Corp
Tax withholding
F$369K
42.6K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

14
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.31M
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$234K
3,016 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
PS
Parker Mark SPresident
HYFMHYDROFARM HOLDINGS GROUP, INC.
Tax withholding
F$2,525
1,672 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
LW
Lopez Anthony WilliamSEE REMARKS
AMPYAmplify Energy Corp.
Tax withholding
F$35K
7,768 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
AE
Ackerman EricaCAO and Corporate Controller
HYFMHYDROFARM HOLDINGS GROUP, INC.
Tax withholding
F$1,037
687 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$100K
2,843 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
KL
Kouzoukas Demetrios L.Director
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
NS
Naylor StuartCHIEF DEV. OFFICER
MGTXMeiraGTx Holdings plc
Option exercise
M—
37.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
AS
Arnaboldi Nicole SDirector
NEENEXTERA ENERGY INC
Grant or award
A$36K
463 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
FT
Foote TimChief Financial Officer
BBBLACKBERRY Ltd
Option exercise
M—
4,616 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Tax withholding
F$34K
4,364 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
WM
Willis Eric M.See Remarks
AMPYAmplify Energy Corp.
Option exercise
M—
29.5K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
LF
Lizzul Paul F.Chief Medical Officer
ANABANAPTYSBIO, INC
Option exercise
M—
6,145 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
LU
Loengard Anna UDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
RG
Robinson William G JrDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
LW
Lopez Anthony WilliamSEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
17.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
NP
Nelson Jonathan PChief Operations Officer
BYNDBEYOND MEAT, INC.
Tax withholding
F$30K
32.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
ZK
Zeldin Robert KCHIEF MEDICAL OFFICER
MGTXMeiraGTx Holdings plc
Option exercise
M—
17.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
GR
Giroux RichardCFO & COO
MGTXMeiraGTx Holdings plc
Option exercise
M—
52.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
LA
Lufkin Paul AndrewSenior Vice President, Sales
BYNDBEYOND MEAT, INC.
Tax withholding
F$28K
30.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
BK
Boone KarenDirector
CRWVCoreWeave, Inc.
Option exercise
M—
1,460 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

12
NS
Naylor StuartCHIEF DEV. OFFICER
MGTXMeiraGTx Holdings plc
Tax withholding
F$136K
17.6K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

12
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$830K
4,783 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

12
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$280K
1,615 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

12
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$493K
2,830 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

12
GR
Giroux RichardCFO & COO
MGTXMeiraGTx Holdings plc
Tax withholding
F$223K
28.8K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

12
ZK
Zeldin Robert KCHIEF MEDICAL OFFICER
MGTXMeiraGTx Holdings plc
Tax withholding
F$52K
6,729 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$116K
1,500 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

11
SK
Shipchandler KhozemaDirector, Chief Executive Officer
TWLOTWILIO INC
Open-market sale · 10b5-1 plan
SELL$290K
2,181 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

11
PS
Peters John SheldonChief Insurance Officer
LMNDLemonade, Inc.
Open-market sale · 10b5-1 plan
SELL$800K
10.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,900 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

9
DN
Dishart NoreenExecutive VP/Chief HR Officer
PRAPROASSURANCE CORP
Grant or award
A—
18.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

9
CB
Curtis Thomas BenjaminPres., BK US & CA
QSRRestaurant Brands International Inc.
Grant or award
A—
67 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

9
ZK
Zeldin Robert KCHIEF MEDICAL OFFICER
MGTXMeiraGTx Holdings plc
Option exercise
M—
17.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
ANABANAPTYSBIO, INC
Grant or award
A—
4,000 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

9
CB
Curtis Thomas BenjaminPres., BK US & CA
QSRRestaurant Brands International Inc.
Grant or award
A—
451 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

9
WO
Warnica Kimberly O.EVP, CLO & Secretary
APAAPA Corp
Grant or award
A—
44.9K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

9
CB
Curtis Thomas BenjaminPres., BK US & CA
QSRRestaurant Brands International Inc.
Grant or award
A—
589 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence